---
title: >-
  Patterns and Predictors of Initiation of Intravenous Bisphosphonates Among
  Patients with Multiple Myeloma in the United States.
description: >-
  Explore this publication on real-world evidence: Patterns and Predictors of
  Initiation of Intravenous Bisphosphonates Among Patients with Multiple Myeloma
  in…
date: '2017-01-01'
category: Publications
tags:
  - American Society Of Hematology Conference
  - Oral Presentation
  - R&D
  - Care
  - Methods/Pharmacoepi
  - Oncology
  - Health System Partner
canonical_url: >-
  https://www.pedestalhealth.com/resources/publications/american-society-of-hematology-conference/patterns-and-predictors-of-initiation-of-intravenous/
source: Pedestal Health
license: © 2026 Pedestal Health. All rights reserved.
slug: patterns-and-predictors-of-initiation-of-intravenous
id: 6cOxBpqSCYljy3UZUWnlOn
contentType: article
---

## Challenge

IV bisphosphonate initiation patterns in multiple myeloma patients—including the clinical factors that predict guideline-concordant versus non-concordant initiation—had not been systematically characterized in a large real-world US oncology population.

## Solution

Target RWE researchers analyzed real-world oncology data to describe patterns and predictors of IV bisphosphonate initiation in multiple myeloma, characterizing demographic, clinical, and practice-level factors associated with treatment initiation rates.

## Impact

Identifying predictors of IV bisphosphonate initiation in multiple myeloma provides oncology drug development partners with evidence for targeting quality improvement efforts and designing interventions to increase guideline-concordant bone health management.